I've heard the phrase "regulating yourself out of the market."
Do you feel this applies here?
Do you feel this applies here?
It's not as clear that it's better to give up on artificial intelligence than to give up on Europe. When your axioms are unsound, you can derive nonsense from them. So yep, it seems Europe isn't going to be the future of machine intelligence, to the astonishment of noone.
The reality is that the EU is a much much smaller market than North America, and expensive to operate in even without onerous AI regulation.
It’s likely easier to support the EU for larger companies, but there is little doubt in my mind that this sort of regulation in the near term will ensure that Europe will always get services much later than NA, and maybe some companies will choose not to bring some products to the EU at all.
So the EU exists strictly in an effort to bully the rest of the world into their continental ideas? I thought the purpose was to provide representation and protection to their own citizens.
> So yep, it seems Europe isn't going to be the future of machine intelligence, to the astonishment of noone.
They mistook State Authority as an end unto itself. Everything else is going to be secondary to that.
Laws like these are unconstitutional and I intend to actively disregard them while still serving customers in those states.
https://www.washingtonpost.com/technology/2023/09/18/califor...
Know your rights.
Do you actually believe cancer treatments are what the EU is going to lose on with these regulations?
Why?
1. If the AI is more effective at finding successful cancer treatment for Little Endians versus Big Endians, then there is a non-zero chance that the AI will be deemed discriminatory. This could play out in a number of ways, but restricted access is certainly one of them. I live in California, and I also think that there is a non-zero chance of this happening here. It all depends on how the treatment and data are presented.
2. If the manufacturer of said treatment is anti-union, will the treatment options be distributable in certain parts of Europe?
As is yours.
Who said anything about where I think this AI would be developed?
US is possible. So is China. So is Europe. Not necessarily in that order. Japan might have an outside chance if certain things line up a certain way.
If Europe and the US make AI research overly cumbersome, I’m sure there are plenty of countries that will offer sweetheart deals to the best teams looking for a new home.
"Drugmakers Boehringer-Ingelheim and Eli Lilly have called off plans to market their Type 2 diabetes drug linagliptin in Germany because new legislation in the country could mean that pill's price could end up being too low."
https://www.reuters.com/article/boehringer-lilly-idINL5E7K23...